British Dragon Durabol contains Nandrolone Phenylpropionate in injectable form, labeled at 100 mg/mL. As a short-acting ester, accurate concentration is important for maintaining consistent dosing and predictable release.
Below is the latest available independent lab test confirming the potency of Durabol, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-20
- Product: Durabol
- Active Substance: Nandrolone Phenylpropionate
- Manufacturer: British Dragon
- Labeled Dosage: 100 mg/mL
- Result: 102.02 mg/mL
- Laboratory: Janoshik
This lab test shows a measured concentration of 102.02 mg/mL, slightly above the labeled 100 mg/mL dosage. This result indicates accurate formulation with a small positive variance.
Potency Analysis
- Labeled dosage: 100 mg/mL
- Measured dosage: 102.02 mg/mL
- Deviation: ~+2.0%
- Laboratory: Janoshik
The measured result shows a slight overfill, which is commonly used in injectable formulations to ensure that the product consistently meets or exceeds its labeled potency.
About Durabol (Nandrolone Phenylpropionate)
Nandrolone Phenylpropionate is a fast-acting ester commonly used in injectable formulations requiring stable and accurate dosing. Maintaining the correct concentration is important for ensuring consistent delivery of the active compound.
Independent lab testing provides transparency by confirming the actual measured potency of a specific batch.
Conclusion
The available lab test for British Dragon Durabol shows a measured concentration of 102.02 mg/mL, slightly exceeding the labeled 100 mg/mL dosage. This result indicates accurate formulation with a controlled positive deviation.
As only one lab report is currently available, additional testing would help confirm long-term batch consistency. However, this initial result demonstrates a reliable potency profile.
Frequently Asked Questions
Yes, the lab test shows a measured concentration of 102.02 mg/mL, which is very close to the labeled dosage.
Yes, small positive deviations are common in injectable formulations to ensure labeled potency is consistently met.
The available report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports would help evaluate consistency across batches.
